GB1313150A - Amino derivatives of furane thiophene and thiazole - Google Patents
Amino derivatives of furane thiophene and thiazoleInfo
- Publication number
- GB1313150A GB1313150A GB4384070A GB4384070A GB1313150A GB 1313150 A GB1313150 A GB 1313150A GB 4384070 A GB4384070 A GB 4384070A GB 4384070 A GB4384070 A GB 4384070A GB 1313150 A GB1313150 A GB 1313150A
- Authority
- GB
- United Kingdom
- Prior art keywords
- butylamino
- reacting
- thiazole
- thiophene
- propylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 title abstract 5
- 150000001412 amines Chemical class 0.000 title abstract 4
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 title abstract 3
- 229930192474 thiophene Natural products 0.000 title abstract 3
- -1 2- thiazolyl Chemical group 0.000 abstract 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 3
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- HCPORNAVHSWTOJ-UHFFFAOYSA-N 1-(2-Furanyl)-1-propanone Chemical compound CCC(=O)C1=CC=CO1 HCPORNAVHSWTOJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 229930194542 Keto Natural products 0.000 abstract 1
- 238000006683 Mannich reaction Methods 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 125000005219 aminonitrile group Chemical group 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052744 lithium Inorganic materials 0.000 abstract 1
- KCTBOHUTRYYLJA-UHFFFAOYSA-N lithium;2h-furan-2-ide Chemical compound [Li+].C=1C=[C-]OC=1 KCTBOHUTRYYLJA-UHFFFAOYSA-N 0.000 abstract 1
- SNHOZPMHMQQMNI-UHFFFAOYSA-N lithium;2h-thiophen-2-ide Chemical compound [Li+].C=1C=[C-]SC=1 SNHOZPMHMQQMNI-UHFFFAOYSA-N 0.000 abstract 1
- 125000004888 n-propyl amino group Chemical group [H]N(*)C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 230000000701 neuroleptic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR6931306A FR2062868B1 (enrdf_load_stackoverflow) | 1969-09-15 | 1969-09-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1313150A true GB1313150A (en) | 1973-04-11 |
Family
ID=9040074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4384070A Expired GB1313150A (en) | 1969-09-15 | 1970-09-14 | Amino derivatives of furane thiophene and thiazole |
Country Status (4)
| Country | Link |
|---|---|
| CA (1) | CA963007A (enrdf_load_stackoverflow) |
| DE (1) | DE2042504B2 (enrdf_load_stackoverflow) |
| FR (1) | FR2062868B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1313150A (enrdf_load_stackoverflow) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0196001A1 (en) * | 1985-03-20 | 1986-10-01 | Ferrer Internacional, S.A. | Thiophene ring-substituted alpha-(alkylaminopropionyl)-thiophene derivatives, a process for preparing them and pharmaceutical compositions containing them |
| EP0248107A1 (en) * | 1986-06-03 | 1987-12-09 | Ferrer Internacional, S.A. | Thiophene ring-substituted alpha-(alkylaminopropionyl)-thiophene derivatives, a process for preparing them and pharmacuetical compositions containing them |
| US10150781B2 (en) | 2014-08-01 | 2018-12-11 | Avexxin As | 2-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders |
| US10259801B2 (en) | 2013-01-29 | 2019-04-16 | Avexxin As | Anti-inflammatory and antitumor 2-oxothiazoles ABD 2-oxothiophenes compounds |
| US10370344B2 (en) | 2009-10-02 | 2019-08-06 | Avexxin As | 2-oxothiazole compounds and method of using same for chronic inflammatory disorders |
| US11439625B2 (en) | 2016-03-14 | 2022-09-13 | Avexxin As | Combination therapy for proliferative diseases |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1151164A (en) * | 1978-01-13 | 1983-08-02 | Atsuyuki Kojima | Conjugated ketone compounds and their production and use |
| FR2453172A1 (fr) * | 1979-04-06 | 1980-10-31 | Innothera Lab Sa | Nouvelles (thienyl-2) amino-1 butyl cetones, leur procede de preparation et leur application en therapeutique |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1214077A (en) * | 1967-11-02 | 1970-12-02 | Usv Pharma Corp | Oximes and their carbamoyl esters and the methods of preparation thereof |
-
1969
- 1969-09-15 FR FR6931306A patent/FR2062868B1/fr not_active Expired
-
1970
- 1970-08-27 DE DE19702042504 patent/DE2042504B2/de active Granted
- 1970-09-14 CA CA093,098*7A patent/CA963007A/en not_active Expired
- 1970-09-14 GB GB4384070A patent/GB1313150A/en not_active Expired
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0196001A1 (en) * | 1985-03-20 | 1986-10-01 | Ferrer Internacional, S.A. | Thiophene ring-substituted alpha-(alkylaminopropionyl)-thiophene derivatives, a process for preparing them and pharmaceutical compositions containing them |
| EP0248107A1 (en) * | 1986-06-03 | 1987-12-09 | Ferrer Internacional, S.A. | Thiophene ring-substituted alpha-(alkylaminopropionyl)-thiophene derivatives, a process for preparing them and pharmacuetical compositions containing them |
| US10370344B2 (en) | 2009-10-02 | 2019-08-06 | Avexxin As | 2-oxothiazole compounds and method of using same for chronic inflammatory disorders |
| US10259801B2 (en) | 2013-01-29 | 2019-04-16 | Avexxin As | Anti-inflammatory and antitumor 2-oxothiazoles ABD 2-oxothiophenes compounds |
| US11034666B2 (en) | 2013-01-29 | 2021-06-15 | Avexxin As | Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds |
| US11691959B2 (en) | 2013-01-29 | 2023-07-04 | Avexxin As | Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds |
| US10150781B2 (en) | 2014-08-01 | 2018-12-11 | Avexxin As | 2-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders |
| US10851114B2 (en) | 2014-08-01 | 2020-12-01 | Avexxin As | 2-oxothiatole compounds having activity as cPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders |
| US11439625B2 (en) | 2016-03-14 | 2022-09-13 | Avexxin As | Combination therapy for proliferative diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2042504A1 (de) | 1971-04-01 |
| DE2042504C3 (enrdf_load_stackoverflow) | 1973-12-06 |
| FR2062868B1 (enrdf_load_stackoverflow) | 1973-08-10 |
| DE2042504B2 (de) | 1973-05-10 |
| CA963007A (en) | 1975-02-18 |
| FR2062868A1 (enrdf_load_stackoverflow) | 1971-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1313150A (en) | Amino derivatives of furane thiophene and thiazole | |
| ES477882A1 (es) | Un procedimiento para la obtencion de nuevos derivados de propanona. | |
| GB1431005A (en) | 6-deoxy-6-substituted or unsubstituted amino-lividomycins and the production thereof | |
| GB1529329A (en) | Pharmaceutical compositions containing piperidylindole derivatives | |
| GB1374299A (en) | Derivatives of 1,2,3,4-tetrahydroisoquinoline production of the same and composition thereof | |
| GB1295570A (enrdf_load_stackoverflow) | ||
| GB1373537A (en) | Aminoalkoxy-benzylidene 2-h-benzothiazine-3-4h-ones and related compounds | |
| GB1061306A (en) | 4-substituted-2-benzhydryl-2-butanol derivatives | |
| GB1195324A (en) | 2,4,5-Triphenyl (and Substituted Triphenyl)-3-Acetonitriles of Pyrrole, Furan and Thiophene | |
| AU606712B2 (en) | Novel 3,5-dihydroxycarboxylic acids and their derivatives, process for their preparation, their use as medicines, pharmaceutical products and intermediate products | |
| GB1464242A (en) | Benzoyl benzofurans and compositions comprising them | |
| ES385640A2 (es) | Un procedimiento para la preparacion de oxinas y sus deri- vados. | |
| GB1472870A (en) | Process for preparing cephalosporins | |
| GB1392270A (en) | Indan-1-carboxamide derivatives | |
| GB1467407A (en) | Process for the manufacture of 7-beta-acylaminoceph-3-em- 4-carboxylic acid compounds | |
| GB1448966A (en) | Amine derivatives of azidophenols | |
| GB1046429A (en) | New 2-(1-naphthyl)-carboxylic acids and pharmaceutical compositions containing them | |
| GB1192162A (en) | Derivatives of Tetrazolyl Alkanoic Acids | |
| GB1057447A (en) | Quinolyl-aminoethanols and process for the preparation thereof | |
| GB1418656A (en) | 6-alpha-amidino-and imidoylaminoalkanoyl-amino-penicillanic acids | |
| GB1300272A (en) | Triheterocyclic compounds | |
| ES416646A2 (es) | Un procedimiento para la preparacion de compuustos de cefa- losporina. | |
| ES446189A1 (es) | Un metodo para preparar nuevos compuestos de oxima-eter. | |
| GB1199731A (en) | Basic Ketones and Derivatives | |
| GB1272416A (en) | Tetracycline derivatives and a process for the preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |